AUDOPHARMA
The computed 12-month bankruptcy probability of AUDOPHARMA is 0.5% (very low). The 2024 annual accounts show equity of €231k and a net result of €68k. Equity remains stable across the filed fiscal years (±1% per year). Its solvency ranks better than 77% of 1225 sector peers (fiscal year 2024). The company has been active since 1981 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €231k |
| Net result | €68k |
| Staff (FTE) | 0.8 |
| Better than sector | 77% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 49.7% | 20.4% | |
| Net result | €68k | €26k | |
| Equity | €231k | €142k | |
| Gross operating margin | €122k | €217k | |
| Staff costs | €35k | €163k |
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €86k |
| Net profit | €68k |
| Cash flow | €85k |
| Staff costs | €35k |
| Income taxes | €1k |
| Dividends | - |
| Total assets | €464k |
| Equity | €231k |
| Debt | €234k |
| of which ≤ 1y | €182k |
| of which > 1y | €52k |
| Working capital | €203k |
| Employees (FTE) | 0.8 |
| 2024 | |
|---|---|
| Current ratio | 2.11 |
| Quick ratio | 1.06 |
| Working capital ratio | 43.6% |
| Solvency | 49.7% |
| Debt / equity | 1.01 |
| Long-term debt ratio | 0.23 |
| Interest coverage | 74.43 |
| Gross margin | - |
| Net margin | - |
| ROA | 14.6% |
| ROE | 29.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €464k |
| Fixed assets | 21/28 | €80k |
| Tangible fixed assets | 22/27 | €80k |
| Current assets | 29/58 | €384k |
| Stocks & contracts in progress | 3 | €191k |
| Amounts receivable within one year | 40/41 | €64k |
| Cash & bank | 54/58 | €129k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €464k |
| Equity | 10/15 | €231k |
| Contributions / capital | 10/11 | €25k |
| Reserves | 13 | €206k |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €234k |
| Amounts payable after one year | 17 | €52k |
| Amounts payable within one year | 42/48 | €182k |
| Trade debts payable within one year | 44 | €84k |
| Income statement | ||
| Gross operating margin | 9900 | €122k |
| Operating result | 9901 | €69k |
| Financial income | 75 | €1k |
| Financial charges | 65 | €1k |
| Result before taxes | 9903 | €69k |
| Income taxes | 67/77 | €1k |
| Net result for the period | 9904 | €68k |
| Result to be appropriated | 9905 | €71k |
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 26-11-1981 |
| Status | Active |
| Postal code | 8660 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 38001E0887/00C004 | Flanders | 209 m² | 1 · 209 m² | 11.4 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
21-02-2023 Discharge granted to the board
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering besluit eveneens dat de d\u00E9charge die zal gegeven worden door de eerstkomende jaarvergadering aan de bestuurder eveneens zal gelden als d\u00E9charge aan de opdracht van de ontslagnemende zaakvoerder",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "dagelijks_bestuur",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Q.V.A.",
"address": "Koksijdestraat 25, 8630 Veurne",
"country": "BE",
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering geeft opdracht en volmacht aan de naamloze vennootschap \u201CQ.V.A.\u201D, met kantoor te 8630 Veurne, Koksijdestraat 25, met mogelijkheid van indeplaatsstelling, alle nuttige en noodzakelijke formaliteiten te vervullen, zo onder andere inzake inschrijving, wijziging, en schrapping van het han",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Pieterjan TAILLY",
"firm_city": null,
"firm_name": null,
"office_city": "Veurne",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-02-21",
"filing_date": "2023-02-17",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-02-17",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-17",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-17",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-17",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-17",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-17",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-17",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-17",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-17",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0422.153.995",
"name_full": "AUDOPHARMA",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Notaris Pieterjan Tailly",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van de akte met inbegrip van de geco\u00F6rdineerde statuten",
"verslag bestuursorgaan"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | AUDOPHARMA |